Open AccessEuglycaemic diabetic ketoacidosis in bariatric surgery patients with type 2 diabetes taking canagliflozin
Author(s) -
Christoffel Van Niekerk,
James R. Wallace,
Mark Takata,
Roger Yu
Publication year - 2018
Publication title -
bmj case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.231
H-Index - 26
ISSN - 1757-790X
DOI - 10.1136/bcr-2017-221527
Subject(s) - medicine , canagliflozin , diabetic ketoacidosis , metabolic acidosis , ketoacidosis , anion gap , type 2 diabetes , diabetes mellitus , acidosis , insulin , surgery , type 1 diabetes , gastroenterology , endocrinology , anesthesia
A 52-year-old type 2 diabetic man previously on canagliflozin developed severe anion gap metabolic acidosis and markedly elevated beta-hydroxybutyrate on postoperative day (POD) 2 status post laparoscopic Roux-en-Y gastric bypass. An insulin drip and aggressive intravenous fluid repletion were initiated, and electrolytes were monitored and repleted. His anion gap closed, and he was discharged on POD 4. This euglycaemic diabetic ketoacidosis prolonged his hospital stay by 2 days.